Global Leuprorelin Drugs Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Leuprorelin Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Leuprorelin Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Tablets
  • 1.2.3 Injections
  • 1.2.4 Implants
• 1.3 Market by Application
  • 1.3.1 Global Leuprorelin Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Central Precocious Puberty
  • 1.3.3 Advanced Prostate Cancer
  • 1.3.4 Uterine Fibroids
  • 1.3.5 Endometriosis
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Leuprorelin Drugs Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Leuprorelin Drugs Revenue by Region
  • 2.2.1 Global Leuprorelin Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Leuprorelin Drugs Revenue by Region (2019-2024)
  • 2.2.3 Global Leuprorelin Drugs Revenue by Region (2025-2030)
  • 2.2.4 Global Leuprorelin Drugs Revenue Market Share by Region (2019-2030)
• 2.3 Global Leuprorelin Drugs Sales Estimates and Forecasts 2019-2030
• 2.4 Global Leuprorelin Drugs Sales by Region
  • 2.4.1 Global Leuprorelin Drugs Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Leuprorelin Drugs Sales by Region (2019-2024)
  • 2.4.3 Global Leuprorelin Drugs Sales by Region (2025-2030)
  • 2.4.4 Global Leuprorelin Drugs Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Leuprorelin Drugs Sales by Manufacturers
  • 3.1.1 Global Leuprorelin Drugs Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Leuprorelin Drugs Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leuprorelin Drugs in 2023
• 3.2 Global Leuprorelin Drugs Revenue by Manufacturers
  • 3.2.1 Global Leuprorelin Drugs Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Leuprorelin Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Leuprorelin Drugs Revenue in 2023
• 3.3 Global Key Players of Leuprorelin Drugs, Industry Ranking, 2021 VS 2022
• 3.4 Global Leuprorelin Drugs Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Leuprorelin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Leuprorelin Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Leuprorelin Drugs, Product Offered and Application
• 3.8 Global Key Manufacturers of Leuprorelin Drugs, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Leuprorelin Drugs Sales by Type
  • 4.1.1 Global Leuprorelin Drugs Historical Sales by Type (2019-2024)
  • 4.1.2 Global Leuprorelin Drugs Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Leuprorelin Drugs Sales Market Share by Type (2019-2030)
• 4.2 Global Leuprorelin Drugs Revenue by Type
  • 4.2.1 Global Leuprorelin Drugs Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Leuprorelin Drugs Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Leuprorelin Drugs Revenue Market Share by Type (2019-2030)
• 4.3 Global Leuprorelin Drugs Price by Type
  • 4.3.1 Global Leuprorelin Drugs Price by Type (2019-2024)
  • 4.3.2 Global Leuprorelin Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Leuprorelin Drugs Sales by Application
  • 5.1.1 Global Leuprorelin Drugs Historical Sales by Application (2019-2024)
  • 5.1.2 Global Leuprorelin Drugs Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Leuprorelin Drugs Sales Market Share by Application (2019-2030)
• 5.2 Global Leuprorelin Drugs Revenue by Application
  • 5.2.1 Global Leuprorelin Drugs Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Leuprorelin Drugs Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Leuprorelin Drugs Revenue Market Share by Application (2019-2030)
• 5.3 Global Leuprorelin Drugs Price by Application
  • 5.3.1 Global Leuprorelin Drugs Price by Application (2019-2024)
  • 5.3.2 Global Leuprorelin Drugs Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Leuprorelin Drugs Market Size by Type
  • 6.1.1 US & Canada Leuprorelin Drugs Sales by Type (2019-2030)
  • 6.1.2 US & Canada Leuprorelin Drugs Revenue by Type (2019-2030)
• 6.2 US & Canada Leuprorelin Drugs Market Size by Application
  • 6.2.1 US & Canada Leuprorelin Drugs Sales by Application (2019-2030)
  • 6.2.2 US & Canada Leuprorelin Drugs Revenue by Application (2019-2030)
• 6.3 US & Canada Leuprorelin Drugs Market Size by Country
  • 6.3.1 US & Canada Leuprorelin Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Leuprorelin Drugs Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Leuprorelin Drugs Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Leuprorelin Drugs Market Size by Type
  • 7.1.1 Europe Leuprorelin Drugs Sales by Type (2019-2030)
  • 7.1.2 Europe Leuprorelin Drugs Revenue by Type (2019-2030)
• 7.2 Europe Leuprorelin Drugs Market Size by Application
  • 7.2.1 Europe Leuprorelin Drugs Sales by Application (2019-2030)
  • 7.2.2 Europe Leuprorelin Drugs Revenue by Application (2019-2030)
• 7.3 Europe Leuprorelin Drugs Market Size by Country
  • 7.3.1 Europe Leuprorelin Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Leuprorelin Drugs Revenue by Country (2019-2030)
  • 7.3.3 Europe Leuprorelin Drugs Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Leuprorelin Drugs Market Size by Type
  • 8.1.1 China Leuprorelin Drugs Sales by Type (2019-2030)
  • 8.1.2 China Leuprorelin Drugs Revenue by Type (2019-2030)
• 8.2 China Leuprorelin Drugs Market Size by Application
  • 8.2.1 China Leuprorelin Drugs Sales by Application (2019-2030)
  • 8.2.2 China Leuprorelin Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Leuprorelin Drugs Market Size by Type
  • 9.1.1 Asia Leuprorelin Drugs Sales by Type (2019-2030)
  • 9.1.2 Asia Leuprorelin Drugs Revenue by Type (2019-2030)
• 9.2 Asia Leuprorelin Drugs Market Size by Application
  • 9.2.1 Asia Leuprorelin Drugs Sales by Application (2019-2030)
  • 9.2.2 Asia Leuprorelin Drugs Revenue by Application (2019-2030)
• 9.3 Asia Leuprorelin Drugs Market Size by Region
  • 9.3.1 Asia Leuprorelin Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Leuprorelin Drugs Revenue by Region (2019-2030)
  • 9.3.3 Asia Leuprorelin Drugs Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Leuprorelin Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Leuprorelin Drugs Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Leuprorelin Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Leuprorelin Drugs Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Leuprorelin Drugs Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Leuprorelin Drugs Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Takeda Pharmaceutical
  • 11.1.1 Takeda Pharmaceutical Company Information
  • 11.1.2 Takeda Pharmaceutical Overview
  • 11.1.3 Takeda Pharmaceutical Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Takeda Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Takeda Pharmaceutical Recent Developments
• 11.2 AbbVie
  • 11.2.1 AbbVie Company Information
  • 11.2.2 AbbVie Overview
  • 11.2.3 AbbVie Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 AbbVie Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 AbbVie Recent Developments
• 11.3 Merck
  • 11.3.1 Merck Company Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Merck Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Merck Recent Developments
• 11.4 Sun Pharmaceutical
  • 11.4.1 Sun Pharmaceutical Company Information
  • 11.4.2 Sun Pharmaceutical Overview
  • 11.4.3 Sun Pharmaceutical Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Sun Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Sun Pharmaceutical Recent Developments
• 11.5 Eugia Pharma
  • 11.5.1 Eugia Pharma Company Information
  • 11.5.2 Eugia Pharma Overview
  • 11.5.3 Eugia Pharma Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Eugia Pharma Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Eugia Pharma Recent Developments
• 11.6 Cipla
  • 11.6.1 Cipla Company Information
  • 11.6.2 Cipla Overview
  • 11.6.3 Cipla Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Cipla Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Cipla Recent Developments
• 11.7 Tolmar
  • 11.7.1 Tolmar Company Information
  • 11.7.2 Tolmar Overview
  • 11.7.3 Tolmar Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Tolmar Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Tolmar Recent Developments
• 11.8 Accord BioPharma
  • 11.8.1 Accord BioPharma Company Information
  • 11.8.2 Accord BioPharma Overview
  • 11.8.3 Accord BioPharma Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Accord BioPharma Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Accord BioPharma Recent Developments
• 11.9 Foresee Pharmaceuticals
  • 11.9.1 Foresee Pharmaceuticals Company Information
  • 11.9.2 Foresee Pharmaceuticals Overview
  • 11.9.3 Foresee Pharmaceuticals Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Foresee Pharmaceuticals Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Foresee Pharmaceuticals Recent Developments
• 11.10 Beijing Biote Pharmaceutical
  • 11.10.1 Beijing Biote Pharmaceutical Company Information
  • 11.10.2 Beijing Biote Pharmaceutical Overview
  • 11.10.3 Beijing Biote Pharmaceutical Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Beijing Biote Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Beijing Biote Pharmaceutical Recent Developments
• 11.11 Livzon Pharmaceutical
  • 11.11.1 Livzon Pharmaceutical Company Information
  • 11.11.2 Livzon Pharmaceutical Overview
  • 11.11.3 Livzon Pharmaceutical Leuprorelin Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Livzon Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Livzon Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Leuprorelin Drugs Industry Chain Analysis
• 12.2 Leuprorelin Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Leuprorelin Drugs Production Mode & Process
• 12.4 Leuprorelin Drugs Sales and Marketing
  • 12.4.1 Leuprorelin Drugs Sales Channels
  • 12.4.2 Leuprorelin Drugs Distributors
• 12.5 Leuprorelin Drugs Customers

13 Leuprorelin Drugs Market Dynamics

• 13.1 Leuprorelin Drugs Industry Trends
• 13.2 Leuprorelin Drugs Market Drivers
• 13.3 Leuprorelin Drugs Market Challenges
• 13.4 Leuprorelin Drugs Market Restraints

14 Key Findings in the Global Leuprorelin Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Leuprorelin Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Tablets

Table 3. Major Manufacturers of Injections

Table 4. Major Manufacturers of Implants

Table 5. Global Leuprorelin Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Leuprorelin Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Leuprorelin Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Leuprorelin Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Leuprorelin Drugs Revenue Market Share by Region (2019-2024)

Table 10. Global Leuprorelin Drugs Revenue Market Share by Region (2025-2030)

Table 11. Global Leuprorelin Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global Leuprorelin Drugs Sales by Region (2019-2024) & (K Units)

Table 13. Global Leuprorelin Drugs Sales by Region (2025-2030) & (K Units)

Table 14. Global Leuprorelin Drugs Sales Market Share by Region (2019-2024)

Table 15. Global Leuprorelin Drugs Sales Market Share by Region (2025-2030)

Table 16. Global Leuprorelin Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Leuprorelin Drugs Sales Share by Manufacturers (2019-2024)

Table 18. Global Leuprorelin Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Leuprorelin Drugs Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Leuprorelin Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Leuprorelin Drugs Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global Leuprorelin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Leuprorelin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprorelin Drugs as of 2023)

Table 24. Global Key Manufacturers of Leuprorelin Drugs, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Leuprorelin Drugs, Product Offered and Application

Table 26. Global Key Manufacturers of Leuprorelin Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 29. Global Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 30. Global Leuprorelin Drugs Sales Share by Type (2019-2024)

Table 31. Global Leuprorelin Drugs Sales Share by Type (2025-2030)

Table 32. Global Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Leuprorelin Drugs Revenue Share by Type (2019-2024)

Table 35. Global Leuprorelin Drugs Revenue Share by Type (2025-2030)

Table 36. Leuprorelin Drugs Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Leuprorelin Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 39. Global Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 40. Global Leuprorelin Drugs Sales Share by Application (2019-2024)

Table 41. Global Leuprorelin Drugs Sales Share by Application (2025-2030)

Table 42. Global Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Leuprorelin Drugs Revenue Share by Application (2019-2024)

Table 45. Global Leuprorelin Drugs Revenue Share by Application (2025-2030)

Table 46. Leuprorelin Drugs Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Leuprorelin Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Leuprorelin Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Leuprorelin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Leuprorelin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Leuprorelin Drugs Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Leuprorelin Drugs Sales by Country (2025-2030) & (K Units)

Table 61. Europe Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 62. Europe Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 63. Europe Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 66. Europe Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 67. Europe Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Leuprorelin Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Leuprorelin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Leuprorelin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Leuprorelin Drugs Sales by Country (2019-2024) & (K Units)

Table 73. Europe Leuprorelin Drugs Sales by Country (2025-2030) & (K Units)

Table 74. China Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 75. China Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 76. China Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 79. China Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 80. China Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 83. Asia Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 84. Asia Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 87. Asia Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 88. Asia Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Leuprorelin Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Leuprorelin Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Leuprorelin Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Leuprorelin Drugs Sales by Region (2019-2024) & (K Units)

Table 94. Asia Leuprorelin Drugs Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Leuprorelin Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Leuprorelin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Leuprorelin Drugs Sales by Country (2025-2030) & (K Units)

Table 108. Takeda Pharmaceutical Company Information

Table 109. Takeda Pharmaceutical Description and Major Businesses

Table 110. Takeda Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Takeda Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Takeda Pharmaceutical Recent Developments

Table 113. AbbVie Company Information

Table 114. AbbVie Description and Major Businesses

Table 115. AbbVie Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. AbbVie Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. AbbVie Recent Developments

Table 118. Merck Company Information

Table 119. Merck Description and Major Businesses

Table 120. Merck Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Merck Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Merck Recent Developments

Table 123. Sun Pharmaceutical Company Information

Table 124. Sun Pharmaceutical Description and Major Businesses

Table 125. Sun Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. Sun Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Sun Pharmaceutical Recent Developments

Table 128. Eugia Pharma Company Information

Table 129. Eugia Pharma Description and Major Businesses

Table 130. Eugia Pharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Eugia Pharma Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Eugia Pharma Recent Developments

Table 133. Cipla Company Information

Table 134. Cipla Description and Major Businesses

Table 135. Cipla Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Cipla Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Cipla Recent Developments

Table 138. Tolmar Company Information

Table 139. Tolmar Description and Major Businesses

Table 140. Tolmar Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. Tolmar Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Tolmar Recent Developments

Table 143. Accord BioPharma Company Information

Table 144. Accord BioPharma Description and Major Businesses

Table 145. Accord BioPharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. Accord BioPharma Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Accord BioPharma Recent Developments

Table 148. Foresee Pharmaceuticals Company Information

Table 149. Foresee Pharmaceuticals Description and Major Businesses

Table 150. Foresee Pharmaceuticals Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. Foresee Pharmaceuticals Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Foresee Pharmaceuticals Recent Developments

Table 153. Beijing Biote Pharmaceutical Company Information

Table 154. Beijing Biote Pharmaceutical Description and Major Businesses

Table 155. Beijing Biote Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 156. Beijing Biote Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Beijing Biote Pharmaceutical Recent Developments

Table 158. Livzon Pharmaceutical Company Information

Table 159. Livzon Pharmaceutical Description and Major Businesses

Table 160. Livzon Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 161. Livzon Pharmaceutical Leuprorelin Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Livzon Pharmaceutical Recent Developments

Table 163. Key Raw Materials Lists

Table 164. Raw Materials Key Suppliers Lists

Table 165. Leuprorelin Drugs Distributors List

Table 166. Leuprorelin Drugs Customers List

Table 167. Leuprorelin Drugs Market Trends

Table 168. Leuprorelin Drugs Market Drivers

Table 169. Leuprorelin Drugs Market Challenges

Table 170. Leuprorelin Drugs Market Restraints

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

List of Figures

Figure 1. Leuprorelin Drugs Product Picture

Figure 2. Global Leuprorelin Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Leuprorelin Drugs Market Share by Type: 2023 & 2030

Figure 4. Tablets Product Picture

Figure 5. Injections Product Picture

Figure 6. Implants Product Picture

Figure 7. Global Leuprorelin Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Leuprorelin Drugs Market Share by Application: 2023 & 2030

Figure 9. Central Precocious Puberty

Figure 10. Advanced Prostate Cancer

Figure 11. Uterine Fibroids

Figure 12. Endometriosis

Figure 13. Other

Figure 14. Leuprorelin Drugs Report Years Considered

Figure 15. Global Leuprorelin Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 17. Global Leuprorelin Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 18. Global Leuprorelin Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 19. Global Leuprorelin Drugs Revenue Market Share by Region (2019-2030)

Figure 20. Global Leuprorelin Drugs Sales (2019-2030) & (K Units)

Figure 21. Global Leuprorelin Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 22. Global Leuprorelin Drugs Sales Market Share by Region (2019-2030)

Figure 23. US & Canada Leuprorelin Drugs Sales YoY (2019-2030) & (K Units)

Figure 24. US & Canada Leuprorelin Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Europe Leuprorelin Drugs Sales YoY (2019-2030) & (K Units)

Figure 26. Europe Leuprorelin Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. China Leuprorelin Drugs Sales YoY (2019-2030) & (K Units)

Figure 28. China Leuprorelin Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Asia (excluding China) Leuprorelin Drugs Sales YoY (2019-2030) & (K Units)

Figure 30. Asia (excluding China) Leuprorelin Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Leuprorelin Drugs Sales YoY (2019-2030) & (K Units)

Figure 32. Middle East, Africa and Latin America Leuprorelin Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 33. Global Leuprorelin Drugs Sales Share by Manufacturers (2023)

Figure 34. The Leuprorelin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 35. Global Leuprorelin Drugs Revenue Share by Manufacturers (2023)

Figure 36. The Top 5 and 10 Largest Manufacturers of Leuprorelin Drugs in the World: Market Share by Leuprorelin Drugs Revenue in 2023

Figure 37. Global Leuprorelin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 38. Global Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 39. Global Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 40. Global Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 41. Global Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 43. US & Canada Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 44. US & Canada Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 45. US & Canada Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 46. US & Canada Leuprorelin Drugs Revenue Share by Country (2019-2030)

Figure 47. US & Canada Leuprorelin Drugs Sales Share by Country (2019-2030)

Figure 48. US Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 49. Canada Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 50. Europe Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 51. Europe Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 52. Europe Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 53. Europe Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 54. Europe Leuprorelin Drugs Revenue Share by Country (2019-2030)

Figure 55. Europe Leuprorelin Drugs Sales Share by Country (2019-2030)

Figure 56. Germany Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. France Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. U.K. Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. Italy Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 60. Russia Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 61. China Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 62. China Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 63. China Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 64. China Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 65. Asia Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 66. Asia Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 67. Asia Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 68. Asia Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 69. Asia Leuprorelin Drugs Revenue Share by Region (2019-2030)

Figure 70. Asia Leuprorelin Drugs Sales Share by Region (2019-2030)

Figure 71. Japan Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. South Korea Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. China Taiwan Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. Southeast Asia Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 75. India Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 76. Australia Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Middle East, Africa and Latin America Leuprorelin Drugs Sales Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America Leuprorelin Drugs Revenue Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Leuprorelin Drugs Sales Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America Leuprorelin Drugs Revenue Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Leuprorelin Drugs Revenue Share by Country (2019-2030)

Figure 82. Middle East, Africa and Latin America Leuprorelin Drugs Sales Share by Country (2019-2030)

Figure 83. Brazil Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. Mexico Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Turkey Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 86. Israel Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 87. GCC Countries Leuprorelin Drugs Revenue (2019-2030) & (US$ Million)

Figure 88. Leuprorelin Drugs Value Chain

Figure 89. Leuprorelin Drugs Production Process

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed